Detalhe da pesquisa
1.
Global Public Perceptions of Genomic Data Sharing: What Shapes the Willingness to Donate DNA and Health Data?
Am J Hum Genet
; 107(4): 743-752, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32946764
2.
Return of genomic results does not motivate intent to participate in research for all: Perspectives across 22 countries.
Genet Med
; 24(5): 1120-1129, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35125311
3.
Trust in genomic data sharing among members of the general public in the UK, USA, Canada and Australia.
Hum Genet
; 138(11-12): 1237-1246, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31531740
4.
Demonstrating trustworthiness when collecting and sharing genomic data: public views across 22 countries.
Genome Med
; 13(1): 92, 2021 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34034801
5.
Members of the public in the USA, UK, Canada and Australia expressing genetic exceptionalism say they are more willing to donate genomic data.
Eur J Hum Genet
; 28(4): 424-434, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31784701
6.
Attitudes of publics who are unwilling to donate DNA data for research.
Eur J Med Genet
; 62(5): 316-323, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30476628
7.
'Your DNA, Your Say': global survey gathering attitudes toward genomics: design, delivery and methods.
Per Med
; 15(4): 311-318, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29856292
8.
Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial.
JAMA Oncol
; 3(7): 913-920, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27787547
9.
Enhanced anti-tumour activity of the combination of the novel MEK inhibitor WX-554 and the novel PI3K inhibitor WX-037.
Cancer Chemother Pharmacol
; 78(6): 1269-1281, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27837257
10.
Body Mass Index and Survival in a Prospective Randomized Trial of Localized High-Risk Renal Cell Carcinoma.
Cancer Epidemiol Biomarkers Prev
; 25(9): 1326-32, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27418270
11.
A phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours.
Eur J Cancer
; 68: 1-10, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27693888
12.
Carbonic anhydrase-IX score is a novel biomarker that predicts recurrence and survival for high-risk, nonmetastatic renal cell carcinoma: Data from the phase III ARISER clinical trial.
Urol Oncol
; 33(5): 204.e25-33, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25823535
13.
Monoclonal antibody G250 targeting CA â ¨: Binding specificity, internalization and therapeutic effects in a non-renal cancer model.
Int J Oncol
; 45(6): 2455-67, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25230982
14.
Carbonic anhydrase IX: role in diagnosis prognosis and cancer therapy. Introduction.
BJU Int
; 101 Suppl 4: 1, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18430114
15.
Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial.
J Clin Oncol
; 31(2): 187-94, 2013 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23213092
16.
Interpretation of genomic copy number variants using DECIPHER.
Curr Protoc Hum Genet
; Chapter 8: Unit 8.14, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22241657
17.
An overview of Ensembl.
Genome Res
; 14(5): 925-8, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15078858
18.
The Role of uPA and uPA Inhibitors in Breast Cancer.
Breast Care (Basel)
; 3(s2): 1-2, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-20824006